| Elizabeth Hanlon Brooks, DO | |
|
1000 Harrington St, Mount Clemens, MI 48043-2920 | |
| (586) 493-8000 | |
| Not Available |
| Full Name | Elizabeth Hanlon Brooks |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 1000 Harrington St, Mount Clemens, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184852204 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 5101018230 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mclaren Macomb | Mount clemens, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inpatient Consultants Of Michigan Pc | 6709891286 | 29 |
News Archive
Today, the National Association for Continence (NAFC) announced findings from a new, nationwide survey of women about overactive bladder (OAB).
The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
No single assessment tool is able to consistently determine driving ability in people with Alzheimer's disease and mild cognitive impairment, a St. Michael's Hospital research review has found.
› Verified 3 days ago
| Entity Name | Inpatient Consultants Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861442824 PECOS PAC ID: 6709891286 Enrollment ID: O20060221000260 |
News Archive
Today, the National Association for Continence (NAFC) announced findings from a new, nationwide survey of women about overactive bladder (OAB).
The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
No single assessment tool is able to consistently determine driving ability in people with Alzheimer's disease and mild cognitive impairment, a St. Michael's Hospital research review has found.
› Verified 3 days ago
| Entity Name | Michigan Post-acute Medical Services 1 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669901567 PECOS PAC ID: 2163798877 Enrollment ID: O20171025001292 |
News Archive
Today, the National Association for Continence (NAFC) announced findings from a new, nationwide survey of women about overactive bladder (OAB).
The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
No single assessment tool is able to consistently determine driving ability in people with Alzheimer's disease and mild cognitive impairment, a St. Michael's Hospital research review has found.
› Verified 3 days ago
| Entity Name | Mi Pacs 2 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205418357 PECOS PAC ID: 2264831577 Enrollment ID: O20210518002473 |
News Archive
Today, the National Association for Continence (NAFC) announced findings from a new, nationwide survey of women about overactive bladder (OAB).
The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
No single assessment tool is able to consistently determine driving ability in people with Alzheimer's disease and mild cognitive impairment, a St. Michael's Hospital research review has found.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Hanlon Brooks, DO 36115 Schoolcraft Rd, Livonia, MI 48150-1216 Ph: (734) 464-0887 | Elizabeth Hanlon Brooks, DO 1000 Harrington St, Mount Clemens, MI 48043-2920 Ph: (586) 493-8000 |
News Archive
Today, the National Association for Continence (NAFC) announced findings from a new, nationwide survey of women about overactive bladder (OAB).
The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.
No single assessment tool is able to consistently determine driving ability in people with Alzheimer's disease and mild cognitive impairment, a St. Michael's Hospital research review has found.
› Verified 3 days ago
Akhlema Paru Haidar, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8142 Fax: 586-493-3250 | |
Dr. Vasudevarao Mandava, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 18 Market St, Suite C, Mount Clemens, MI 48043 Phone: 586-783-2222 Fax: 586-783-6280 | |
Robert A Chang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 S Main St, Mount Clemens, MI 48043 Phone: 586-468-1600 Fax: 586-465-0329 | |
Jayne Olivia Mitchell, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000 | |
Misha Kaur Chowdhary, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-3727 | |
Travis Singh Sekhon, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-3727 | |
John Florian Kazmierski, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1030 Harrington St, Suite 101, Mount Clemens, MI 48043 Phone: 586-468-8500 Fax: 586-468-7997 |